JPMorgan Assumes Zymeworks (ZYME) at Neutral
Tweet Send to a Friend
JPMorgan analyst Brian Cheng assumes coverage on Zymeworks (NYSE: ZYME) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE